tirzepatide weight loss vs semaglutide efficacy for in Adults With Overweight or Obesity Tirzepatide vs. Semaglutide: Which GLP-1

37 A reader who is skeptical of GLP-1s cause muscle loss headlines should be equally skeptical of this program added 5 pounds of muscle in 8 weeks headlines

There is no official FDA indication for GLP-1 medications in treating substance use disorders, and the relationship remains an area of active investigation rather than established clinical practice

Join TrueSport Champion Network to help promote the positive values of cheer, dance, and STUNT

The relative greenhouse gas impacts of realistic dietary choices

Serious side effects requiring medical attention Tirzepatide carries a boxed warning about thyroid C-cell tumors

Patients who stopped taking GLP-1s for two years faced up to a 22% increased risk of cardiovascular events compared with those who stayed on the medication, largely erasing all the heart-protective benefits they had built up during treatment